{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-117771","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.777114+00:00","generated_at":"2026-05-22T00:12:36.626144+00:00","sec_items":["5.07"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Royalty Pharma shareholders approve internalization deal; all director nominees elected","bullets":["Proposal 2 (Membership Interest Purchase Agreement internalization) approved with 440.5M For, 74K Against.","All nine director nominees elected, including Pablo Legorreta, Henry Fernandez, Bonnie Bassler.","Advisory say-on-pay (Proposal 7) passed with 403.2M For, 36.8M Against.","Appointment of Ernst & Young as auditor ratified with 493.5M For, 116K Against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-117771","json":"https://secwatch.observer/filing/0001193125-25-117771.json","markdown":"https://secwatch.observer/filing/0001193125-25-117771.md","text":"https://secwatch.observer/filing/0001193125-25-117771.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525117771/0001193125-25-117771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525117771/d52049d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T00:12:36.626144+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}